Weirich J, Antoni H
Physiologisches Institut Universität Freiburg.
Z Kardiol. 1991 Mar;80(3):177-86.
The primary action of class-1-antiarrhythmic drugs is due to blockade of cardiac sodium channels and shows drug-specific frequency dependence, i.e., increasing blockade with increasing stimulation frequency. However, this increasing blockade saturates at higher rates. This behavior can be explained by a periodical binding and unbinding reaction of drug molecules with channel binding sites (periodical ligand binding). The analysis of the saturation behavior of frequency-dependent block of 12 class-1-antiarrhythmic drugs clusters into three groups (I-III), which do not coincide with the commonly used subclassification (1a-1c). However, from the saturation behavior of block and its onset-kinetics (rate of increase of block upon increasing the frequency) found with these groups, three different profiles of antiarrhythmic and proarrhythmic efficacy can be deduced. Thus, saturation in the frequency range above 120/min combined with slow onset-kinetics may create a higher risk of exercise-induced proarrhythmic effects, if agents with such characteristics are given at a concentration sufficiently high to suppress extrasystoles. Therefore, a subdivision of class-1-antiarrhythmic drugs according to the saturation behavior of frequency-dependent block and its onset-kinetics is proposed.
I类抗心律失常药物的主要作用是由于其对心脏钠通道的阻滞,并且表现出药物特异性的频率依赖性,即随着刺激频率增加,阻滞作用增强。然而,这种增强的阻滞作用在更高频率时会达到饱和。这种现象可以通过药物分子与通道结合位点的周期性结合和解离反应(周期性配体结合)来解释。对12种I类抗心律失常药物频率依赖性阻滞的饱和行为分析可分为三组(I - III组),这与常用的亚分类(1a - 1c)并不一致。然而,根据这些组所发现的阻滞饱和行为及其起始动力学(频率增加时阻滞增加的速率),可以推导出三种不同的抗心律失常和促心律失常疗效特征。因此,如果给予具有此类特征的药物,且浓度足够高以抑制期前收缩,那么在频率高于120次/分钟的范围内出现饱和且起始动力学缓慢,可能会增加运动诱发促心律失常效应的风险。因此,建议根据频率依赖性阻滞的饱和行为及其起始动力学对I类抗心律失常药物进行细分。